nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A guide for reporting the results of population pharmacokinetic analyses: A Swedish perspective
|
Wade, Janet R. |
|
2005 |
7 |
2 |
p. E456-E460 |
artikel |
2 |
A guide for reporting the results of population pharmacokinetic analyses: A Swedish perspective
|
Wade, Janet R. |
|
|
7 |
2 |
|
artikel |
3 |
A pragmatic approach to the design of population pharmacokinetic studies
|
Roy, Amit |
|
2005 |
7 |
2 |
p. E408-E420 |
artikel |
4 |
Challenges and issues in veterinary pharmacology and animal health 2004—Preface
|
Martinez, Marilyn |
|
2005 |
7 |
2 |
p. E266-E271 |
artikel |
5 |
Challenges and issues in veterinary pharmacology and animal health 2004—Preface
|
Martinez, Marilyn |
|
|
7 |
2 |
|
artikel |
6 |
Challenges in the transition to model-based development
|
Grasela, Thaddeus H. |
|
2005 |
7 |
2 |
p. E488-E495 |
artikel |
7 |
Challenges with the development and approval of pharmaceuticals for fish
|
Storey, Susan |
|
2005 |
7 |
2 |
p. E335-E343 |
artikel |
8 |
DARPP-32 mediates the actions of multiple drugs of abuse
|
Svenningsson, Per |
|
2005 |
7 |
2 |
p. E353-E360 |
artikel |
9 |
Drug compounding for veterinary patients
|
Papich, Mark G. |
|
2005 |
7 |
2 |
p. E281-E287 |
artikel |
10 |
Editorial: Theme issue “Drug addiction—From basic research to therapies”
|
Rapaka, Rao S. |
|
2005 |
7 |
2 |
p. E344 |
artikel |
11 |
Editorial: Theme issue “Drug addiction—From basic research to therapies”
|
Rapaka, Rao S. |
|
|
7 |
2 |
|
artikel |
12 |
Evidence of effectiveness: How much can we extrapolate from existing studies?
|
Lee, Howard |
|
2005 |
7 |
2 |
p. E467-E474 |
artikel |
13 |
Fish drug analysis—Phish-pharm: A searchable database of pharmacokinetics data in fish
|
Reimschuessel, Renate |
|
2005 |
7 |
2 |
p. E288-E327 |
artikel |
14 |
Further advances in the synthesis of endocannabinoid-related ligands
|
Mahadevan, Anu |
|
2005 |
7 |
2 |
p. E496-E502 |
artikel |
15 |
Homology modeling of opioid receptor-ligand complexes using experimental constraints
|
Pogozheva, Irina D. |
|
2005 |
7 |
2 |
p. E434-E448 |
artikel |
16 |
Modeling and simulation of adherence: Approaches and applications in therapeutics
|
Kenna, Leslie A. |
|
2005 |
7 |
2 |
p. E390-E407 |
artikel |
17 |
Modeling and simulation of adherence: Approaches and applications in therapeutics
|
Kenna, Leslie A. |
|
|
7 |
2 |
|
artikel |
18 |
Neuropeptide-processing enzymes: Applications for drug discovery
|
Fricker, Lloyd D. |
|
2005 |
7 |
2 |
p. E449-E455 |
artikel |
19 |
On some “disadvantages” of the population approach
|
Nedelman, Jerry R. |
|
2005 |
7 |
2 |
p. E374-E382 |
artikel |
20 |
Pharmacodynamic parameter estimation: Population size versus number of samples
|
Girgis, Suzette |
|
2005 |
7 |
2 |
p. E461-E466 |
artikel |
21 |
Pharmacodynamic parameter estimation: Population size versus number of samples
|
Girgis, Suzette |
|
|
7 |
2 |
|
artikel |
22 |
Population pharmacokinetics: A memorial tribute to Lewis Sheiner
|
Mould, Diane R. |
|
2005 |
7 |
2 |
p. E361-E362 |
artikel |
23 |
Population pharmacokinetics/pharmacodynamics of anesthetics
|
Olofsen, Erik |
|
2005 |
7 |
2 |
p. E383-E389 |
artikel |
24 |
Population pharmacokinetics/pharmacodynamics of anesthetics
|
Olofsen, Erik |
|
|
7 |
2 |
|
artikel |
25 |
Population pharmacokinetic studies in pediatrics: Issues in design and analysis
|
Meibohm, Bernd |
|
2005 |
7 |
2 |
p. E475-E487 |
artikel |
26 |
Population pharmacokinetic studies in pediatrics: Issues in design and analysis
|
Meibohm, Bernd |
|
|
7 |
2 |
|
artikel |
27 |
Postexposure management and treatment of anthrax in dogs—Executive councils of the American academy of veterinary pharmacology and therapeutics and the American college of veterinary clinical pharmacology
|
Langston, Cory |
|
2005 |
7 |
2 |
p. E272-E273 |
artikel |
28 |
Recommended reading in population pharmacokinetic pharmacodynamics
|
Bonate, Peter L. |
|
2005 |
7 |
2 |
p. E363-E373 |
artikel |
29 |
Serotonin transporters: Implications for antidepressant drug development
|
White, Kellie J. |
|
2005 |
7 |
2 |
p. E421-E433 |
artikel |
30 |
Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP
|
Zaveri, Nurulain |
|
2005 |
7 |
2 |
p. E345-E352 |
artikel |
31 |
The joint food and agriculture organization of the united nations/world health organization expert committee on food additives and its role in the evaluation of the safety of veterinary drug residues in foods
|
MacNeil, James D. |
|
2005 |
7 |
2 |
p. E274-E280 |
artikel |
32 |
The joint food and agriculture organization of the united nations/world health organization expert committee on food additives and its role in the evaluation of the safety of veterinary drug residues in foods
|
MacNeil, James D. |
|
|
7 |
2 |
|
artikel |
33 |
Use of anatomical and kinetic models in the evaluation of human food additive safety
|
Roth, William L. |
|
2005 |
7 |
2 |
p. E328-E334 |
artikel |